Over 9 million individuals globally struggle with Parkinson's disease, facing symptoms like tremors and mobility freezes that ...

An international team of leading neuro-oncology researchers and clinicians has released new recommendations for good clinical practice regarding the use of artificial intelligence methods to more ...

“Scientists and scientific institutions for decades have been among the most venerated, respected, and trusted institutions ...

On Thursday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $87.59 which represents a decrease of $-1.18 or -1.33% from the prior close of $88.77. The stock opened at ...

In a report released today, Michael Matson from Needham maintained a Buy rating on Haemonetics (HAE – Research Report), with a price ...

Researchers have found teaching artistic observation to neurology residents contributed to the development of well-rounded physicians with the capacity to be both skilled clinicians and compassionate ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

Between 2010 and 2022, cardiovascular mortality increased in rural areas and decreased in urban areas, according to a study ...

Eating a variety of fruits and vegetables, for example, provides not only vitamins and minerals but helpful fiber, which is important for heart health. Some people might benefit from certain ...

Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Boston Scientific (BSX). But which of these two companies is the best option for ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).